To our knowledge, this is the first description of dermatomyositis exacerbated or induced by interferon beta treatment. Our results demonstrate enhanced type I IFN signaling following interferon beta treatment in our patient with dermatomyositis.
No takes yet. Share an insight, caveat, or question.
Somani et al. (2008) studied this question.